Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults-Reference-Cited by-同舟云学术

Development of a physiology-directed population pharmacokinetic and pharmacodynamic model for characterizing the impact of genetic and demographic factors on clopidogrel response in healthy adults

Published:2016-01 Issue: Volume:82 Page:64-78
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Jiang Xi-Ling,Samant Snehal,Lewis Joshua P.,Horenstein Richard B.,Shuldiner Alan R.,Yerges-Armstrong Laura M.,Peletier Lambertus A.,Lesko Lawrence J.,Schmidt Stephan

Funder

NIH/NCATS Clinical and Translational Science Award

NIH

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference67 articles.

1. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives;Angiolillo;J. Am. Coll. Cardiol.,2007

2. Influence of CYP2C19 genotype on the pharmacokinetics of R483, a CYP2C19 substrate, in healthy subjects and type 2 diabetes patients;Bogman;Eur. J. Clin. Pharmacol.,2010

3. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate;Bonello;J. Am. Coll. Cardiol.,2010

4. Paraoxonase-1 is a major determinant of clopidogrel efficacy;Bouman;Nat. Med.,2011

5. High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2);Collet;JACC Cardiovasc. Interv.,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Trial on the Pharmacokinetics of Clopidogrel in Hemodialysis Patients;Kidney International Reports;2024-07

2. Integrating Clopidogrel’s First-Pass Effect in a Joint Semi-Physiological Population Pharmacokinetic Model of the Drug and Its Inactive Carboxylic Acid Metabolite;Pharmaceutics;2024-05-20

3. Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology;Biochemical Pharmacology;2024-05

4. Population Pharmacokinetic/Pharmacodynamic Models for P2Y12 Inhibitors: A Systematic Review and Clinical Appraisal Using Exposure Simulation;Clinical Pharmacokinetics;2024-01-20

5. Advances and Perspectives in methods for identifying high platelet reactivity;Heliyon;2023-12